JFS Wealth Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40
| Closed | -$204 | – | 1987 |
|
|
2024
Q1 | $204 | Buy |
40
+5
| +14% | +$26 | ﹤0.01% | 1893 |
|
|
2023
Q4 | $210 | Sell |
35
-33
| -49% | -$198 | ﹤0.01% | 1898 |
|
|
2023
Q3 | $482 | Buy |
68
+15
| +28% | +$106 | ﹤0.01% | 1754 |
|
|
2023
Q2 | $374 | Buy |
53
+29
| +121% | +$205 | ﹤0.01% | 1799 |
|
|
2023
Q1 | $201 | Sell |
24
-34
| -59% | -$285 | ﹤0.01% | 1828 |
|
|
2022
Q4 | $666 | Sell |
58
-3
| -5% | -$34 | ﹤0.01% | 1685 |
|
|
2022
Q3 | $1K | Buy |
61
+32
| +110% | +$525 | ﹤0.01% | 1482 |
|
|
2022
Q2 | $0 | Sell |
29
-14
| -33% | – | ﹤0.01% | 1738 |
|
|
2022
Q1 | $1K | Buy |
43
+31
| +258% | +$721 | ﹤0.01% | 1579 |
|
|
2021
Q4 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1714 |
|